Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation. Read more about Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation.
Targeting immune hubs to advance cancer immunotherapy. Read more about Targeting immune hubs to advance cancer immunotherapy.
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine. Read more about A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.
Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity. Read more about Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity.
T cell receptor precision editing of regulatory T cells for celiac disease. Read more about T cell receptor precision editing of regulatory T cells for celiac disease.
The T cell receptor landscape of childhood brain tumors. Read more about The T cell receptor landscape of childhood brain tumors.
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection. Read more about Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection.
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency. Read more about Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.
Harnessing regulatory T cells to establish immune tolerance. Read more about Harnessing regulatory T cells to establish immune tolerance.
Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD. Read more about Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD.
